Feng‐Hua Wang

机构：Sun Yat-sen University, Cancer Hospital of Chinese Academy of Medical Sciences, Sun Yat-sen University Cancer Center · ORCID：0000-0003-1016-6867

发表论文 197 篇 · 总被引 7006 次 · h-index 43

代表论文

• The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023 (2023 · 癌症：英文版 · 被引 410)
• Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial (2024 · Nature Medicine · 被引 174)
• Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial (2024 · PLoS Medicine · 被引 19)
• Nd microalloying significantly enhances precipitation strengthening of Mg-Gd-Y-Zn-Zr alloy (2025 · Journal of Alloys and Compounds · 被引 18)
• Clinical outcomes and biomarker exploration of first-line PD-1 inhibitors plus chemotherapy in patients with low PD-L1-expressing of gastric or gastroesophageal junction adenocarcinoma (2024 · Cancer Immunology Immunotherapy · 被引 17)
• Safety, Pharmacokinetics, and Pharmacodynamics Evaluation of Ivonescimab, a Novel Bispecific Antibody Targeting PD ‐1 and VEGF , in Chinese Patients With Advanced Solid Tumors (2025 · Cancer Medicine · 被引 11)